GSK Meningococcal MenACWY Conjugate Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Meningococcal MenACWY Conjugate Vaccine, covering 2025-03-04 to 2025-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety and Immunogenicity of GSK Meningococcal Group B Vaccine When Administered Concomitantly With GSK Meningococcal MenACWY Conjugate Vaccine in Healthy Subjects of 16-18 Years of Age [Phase 3]